Heparin-induced thrombocytopenia (HIT) is the most important and most frequent drug-induced, immune-mediated type of thrombocytopenia. It is associated with significant morbidity and mortality if unrecognized. In this review, we briefly discuss the main features of heparin-induced thrombocytopenia, particularly analyzing the most recent advances in the pathophysiology, diagnosis and treatment of this syndrome. © 2005 Franchini; licensee BioMed Central Ltd.
CITATION STYLE
Franchini, M. (2005, October 4). Heparin-induced thrombocytopenia: An update. Thrombosis Journal. https://doi.org/10.1186/1477-9560-3-14
Mendeley helps you to discover research relevant for your work.